Treating pediatric nonalcoholic fatty liver disease with cysteamine: Is adiponectin the key?

Journal of Pediatrics

Volumn 161, Issue 4, 2012, Pages 579-581

  Xanthakos, Stavra A ^a   Kohli, Rohit ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; MERCAPTAMINE; POLYMER;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILDHOOD DISEASE; EDITORIAL; ENDOPLASMIC RETICULUM STRESS; HUMAN; INSULIN RESISTANCE; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN MULTIMERIZATION;

ADIPONECTIN; CYSTEAMINE; HUMANS; PROTEIN MULTIMERIZATION;

EID: 84866731997     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2012.05.052     Document Type: Editorial

References (16)

1. R. Dohil, L. Meyer, S. Schmeltzer, B.L. Cabrera, J.E. Lavine, and S.A. Phillips The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects J Pediatr 161 2012 639 645
2. J.B. Schwimmer, R. Deutsch, T. Kahen, J.E. Lavine, C. Stanley, and C. Behling Prevalence of fatty liver in children and adolescents Pediatrics 118 2006 1388 1393 (Pubitemid 46393782)
3. M.R. Charlton, J.M. Burns, R.A. Pedersen, K.D. Watt, J.K. Heimbach, and R.A. Dierkhising Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States Gastroenterology 141 2011 1249 1253
4. V. Nobili, M. Manco, R. Devito, V. Di Ciommo, D. Comparcola, and M.R. Sartorelli Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial Hepatology 48 2008 119 128 (Pubitemid 351975537)
5. J.E. Lavine, J.B. Schwimmer, M.L. Van Natta, J.P. Molleston, K.F. Murray, and P. Rosenthal Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial JAMA 305 2011 1659 1668
6. G. Bjelakovic, D. Nikolova, L.L. Gluud, R.G. Simonetti, and C. Gluud Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases Cochrane Database Syst Rev 3 2008 CD007176
7. E.A. Klein, I.M. Thompson Jr., C.M. Tangen, J.J. Crowley, M.S. Lucia, and P.J. Goodman Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA 306 2011 1549 1556
8. S.C. Lu Regulation of glutathione synthesis Mol Aspects Med 30 2009 42 59
9. R. Dohil, S. Schmeltzer, B.L. Cabrera, T. Wang, J. Durelle, and K.B. Duke Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease Aliment Pharmacol Ther 33 2011 1036 1044
10. J.M. Hui, A. Hodge, G.C. Farrell, J.G. Kench, A. Kriketos, and J. George Beyond insulin resistance in NASH: TNFalpha or adiponectin? Hepatology 40 2004 46 54 (Pubitemid 38868922)
11. S. Li, H.J. Shin, E.L. Ding, and R.M. van Dam Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis JAMA 302 2009 179 188
12. Y. Liu, R. Retnakaran, A. Hanley, R. Tungtrongchitr, C. Shaw, and G. Sweeney Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects J Clin Endocrinol Metab 92 2007 4313 4318 (Pubitemid 350074750)
13. Y. Wang, K.S. Lam, M.H. Yau, and A. Xu Post-translational modifications of adiponectin: mechanisms and functional implications Biochem J 409 2008 623 633 (Pubitemid 351214189)
14. K. Tomita, Y. Oike, T. Teratani, T. Taguchi, M. Noguchi, and T. Suzuki Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice Hepatology 48 2008 458 473
15. A. Gastaldelli, S. Harrison, R. Belfort-Aguiar, J. Hardies, B. Balas, and S. Schenker Pioglitazone in the treatment of NASH: the role of adiponectin Aliment Pharmacol Ther 32 2010 769 775
16. National Institute of Diabetes and Digestive and Kidney Diseases. NIH study to test treatment for fatty liver disease in children. http://www.nih.gov/news/health/jan2012/niddk-2011.htm. Accessed January 30, 2012.